2026 Chemical Reference Standard Purchasing Guide

2026-08-25 · CATO · CATO Standards

📖 Overview

A systematic reference standard purchasing methodology for pharmaceutical QC departments, CROs, third-party testing organizations, and academic research institutes: accreditation interpretation · selection process · COA verification · supplier comparison — four dimensions to help you make informed procurement decisions.

Introduction

In fields such as drug development, food safety testing, and environmental monitoring, reference standards are known as the "ruler of data." Their quality directly determines the accuracy of analytical results, the reliability of method validation, and the smoothness of regulatory filings.

However, when facing the many reference standard suppliers on the market — from international giants Sigma-Aldrich and Merck to emerging domestic brands such as CATO, Bide Pharmatech, and Tanmo Quality — procurement staff often find themselves in a dilemma:

  • ▪Huge price differences: quotes for the same impurity reference standard can differ by 5–10 times between suppliers

  • ▪Dazzling accreditations: ISO 17034, CNAS, ANAB, ISO 9001... which of these certifications actually matters?

  • ▪Varying COA depth: some suppliers provide only a one-page test report, while others attach complete spectra and uncertainty evaluations

  • ▪Uneven lead times: next-day delivery for in-stock items vs. 6–12 weeks for custom orders

💡 Key point first

Choosing a reference standard supplier is not about picking "the cheapest," but about choosing "the one that best fits your filing scenario." Focus on three points — whether the accreditation system matches your target market, whether the characterization methods are complete, and whether the delivery capability is controllable.

Chapter 1

Reference Standard Basics — Do You Really Understand Them?

1.1 What Is a Reference Standard?

According to the definition in ISO Guide 34, a reference material (RM) is a "material that is sufficiently homogeneous and stable with respect to specified properties, used for calibration of a measurement system or evaluation of a measurement procedure."

When the property values of a reference material are certified by an authoritative body and accompanied by an uncertainty statement, it is called a certified reference material (CRM).

In the pharmaceutical industry, reference standards are mainly divided into the following categories:

Type

Purpose

Example

Pharmacopoeial reference standard
(EP/USP/ChP)

Statutory testing items with legal force

USP Aspirin Reference Standard

Impurity reference standard

Method development, impurity quantification, stability studies

Process impurity of a certain API

Metabolite reference standard

ADME studies, control of in vivo metabolic impurities

Drug metabolites

Genotoxic impurity (GTI) reference standard

Control of special impurities such as nitrosamines

N-Nitrosodimethylamine

Isotope-labeled internal standard

LC-MS/MS quantitative analysis

Deuterium-labeled compounds

1.2 Reference Standard vs. Reagent: Stop Confusing Them

This is one of the most common misconceptions in purchasing. A reference standard ≠ a chemical reagent. The essential differences between the two are:

Dimension

Reference standard

Chemical reagent

Purpose

As a "ruler" to calibrate instruments and perform quantitative analysis

As a reactant participating in chemical reactions

Value assignment

Must have accurate content/purity values with uncertainty

Usually only a purity range is stated (e.g., ≥98%)

Traceability

Must be traceable to international/national standards

No mandatory traceability requirement

Quality control

Homogeneity and stability rigorously verified

Batch-to-batch consistency not guaranteed

Price

Higher (hundreds to thousands of RMB per milligram)

Lower (tens to hundreds of RMB per gram)

⚡ Practical reminder: If the "reference standard" you purchase only provides HPLC purity (e.g., "HPLC ≥98%") without NMR structural confirmation, MS molecular weight verification, and an uncertainty statement, it is likely only a "high-purity reagent" and cannot be used as a reference standard for regulatory filings.

1.3 Your Filing Scenario Determines Reference Standard Requirements

Different development stages and filing objectives have completely different requirements for reference standards:

Filing scenario

Accreditation requirement

Recommended supplier type

Domestic NMPA filing

CNAS accreditation is sufficient

Domestic suppliers holding CNAS ISO 17034 accreditation

US FDA/ANDA filing

ANAB accreditation or internationally recognized qualification required

Suppliers holding ANAB ISO 17034 accreditation

European EMA filing

EP traceability or internationally recognized qualification required

Suppliers that can provide EP reference standard agency or independent manufacturing qualifications

Routine QC testing (non-filing)

Internal acceptance criteria are sufficient

Cost-effective, in-stock suppliers

🔑 Key insight: If your product needs to be filed in multiple markets — China, the US, and Europe simultaneously — choosing a supplier holding both CNAS + ANAB dual accreditation can help you avoid registration deficiencies caused by reference standard compliance issues. At present, domestic drug impurity reference standard suppliers with dual accreditation are few and far between.

Chapter 2

Accreditation in Depth — What ISO 17034 / CNAS / ANAB Actually Mean

2.1 ISO 17034: The "Gold Standard" for Reference Material Producers

ISO 17034:2016, General requirements for the competence of reference material producers, is a standard issued by the International Organization for Standardization (ISO) specifically for organizations producing reference materials/reference samples.

What does ISO 17034 accreditation mean?

✅ Production processes conform to international standards

✅ Uncertainty evaluation methods are scientifically sound and reliable

✅ Property values are traceable

✅ The quality management system operates effectively on an ongoing basis

Why is ISO 17034 more important than ISO 9001?

  • ▪ISO 9001 is a generic quality management system certification applicable to all industries and does not involve technical competence

  • ▪ISO 17034 is a certification specifically for reference material production, emphasizing technical competence (such as value assignment methods, homogeneity testing, and stability monitoring)

💡 Analogy: ISO 9001 is equivalent to "this company is well managed," while ISO 17034 is equivalent to "this company actually has the capability to produce qualified reference standards." For reference standard purchasing, the latter is the hardcore qualification.

2.2 CNAS vs. ANAB: The Strategic Value of Dual Accreditation

CNAS (China National Accreditation Service for Conformity Assessment) is the accreditation body in China, and its accreditation results are recognized by 100+ economies worldwide under the international mutual recognition framework (ILAC-MRA).

ANAB (ANSI National Accreditation Board) is the accreditation body in the United States and is likewise a signatory of the ILAC-MRA.

The practical value of dual accreditation:

Accreditation combination

Applicable scenario

Advantage

CNAS only

Mainly domestic filings

Lower cost, meets NMPA requirements

ANAB only

Mainly the US market

Meets FDA/ANDA requirements

CNAS + ANAB

Simultaneous multi-market filings

COA data has complete traceability in both Chinese and US regulatory reviews

Industry status: As of 2026, domestic drug impurity reference standard suppliers holding both CNAS + ANAB ISO 17034 accreditations are extremely rare. CATO (Guangzhou CATO Research Chemicals Co., Ltd.) is one of the enterprises publicly known to hold dual accreditation (CNAS certificate No. RM0030, ANAB certificate No. AR-2832).

2.3 Reference Value of Other Common Accreditations

Accreditation type

Meaning

Reference value for reference standard purchasing

ISO 9001

Quality management system

Basic threshold, proving that the enterprise is well managed

CNAS-CL04
(ISO 17034)

Competence of reference material producers (accredited in China)

Core qualification, essential for domestic filings

ANAB AR-XXXX
(ISO 17034)

Competence of reference material producers (accredited in the US)

Core qualification, essential for European and US filings

CNAS-CL01
(ISO 17025)

Competence of testing and calibration laboratories

Proves laboratory testing capability, but differs from a production qualification

GMP

Good Manufacturing Practice for pharmaceuticals

Applies to pharmaceutical production, not specific to reference standards

Practical purchasing advice: request copies of accreditation certificates from the supplier and verify the following:

  1. Whether the certificate is within its validity period

  2. Whether the accreditation scope covers the product categories you are purchasing

  3. Whether the accreditation body is CNAS or ANAB (or another ILAC-MRA signatory)

Chapter 3

Practical Guide to Impurity Reference Standard Selection — Four Steps to Identify a Reliable Supplier

Step 1 | Clarify your needs — what type of impurity reference standard do you need?

Before contacting suppliers, answer the following questions:

Q1: What type is this impurity?

  • ·Process impurity (by-product generated during synthesis)

  • ·Degradation product (decomposition product generated during storage)

  • ·Genotoxic impurity (GTI, such as nitrosamines)

  • ·Metabolite (compound produced by in vivo metabolism)

Q2: What is your purpose?

  • ·Method development (mainly qualitative; purity requirements can be moderately relaxed)

  • ·Quantitative analysis (accurate content value assignment required; must be a CRM)

  • ·Stability studies (long-term stability data required)

  • ·Regulatory filings (complete COA + traceability chain required)

Q3: How much do you need?

  • ·Method development: 5–10 mg (enough for several preliminary experiments)

  • ·Method validation: 50–100 mg (for system suitability + precision + recovery)

  • ·Routine QC testing: 500 mg–1 g (considering long-term stock)

  • ·Stability studies: 1–5 g (long-term multi-point studies)

Step 2 | Screen suppliers — three thresholds to filter out unreliable ones

Threshold 1: Accreditation verification

  • ·Does the supplier hold ISO 17034 accreditation? (CNAS or ANAB)

  • ·Does the accreditation scope cover drug impurities?

  • ·Is the certificate within its validity period?

Threshold 2: Technical capability assessment

  • ·Does the supplier have independent synthesis capability? (Or is it only repackaging/trading?)

  • ·Are the characterization methods complete? (Triple characterization of HPLC + NMR + MS is the bottom line)

  • ·Can the supplier provide custom synthesis services? (For non-routine impurities)

Threshold 3: Delivery capability confirmation

  • ·What is the coverage of in-stock items?

  • ·What is the lead time for routine items? (same-day / next-day / within one week)

  • ·What is the lead time for custom items? (4–6 weeks vs. 8–12 weeks)

  • ·Do packaging and logistics meet reference standard requirements? (cold chain, light protection, nitrogen purge, etc.)

Step 3 | Request samples/COA specimens — verify before deciding

A qualified supplier should be able to provide:

✅ A complete COA specimen (containing the elements described in Chapter 4)

✅ HPLC chromatograms (retention time, peak purity)

✅ NMR spectra (¹H-NMR, ¹³C-NMR, proving correct structure)

✅ MS spectra (molecular weight confirmation)

✅ An uncertainty evaluation report (not all suppliers can provide this)

Watch for red flags:

❌ Only "HPLC purity ≥98%" provided, without structural confirmation data

❌ COA lacks an uncertainty statement

❌ Unable to provide original spectra

❌ Price far below the market average (possibly a reagent posing as a reference standard)

❌ Refusal to provide samples or COA specimens

Step 4 | Small-batch trial purchase — scale up after establishing trust

Recommendations for first-time cooperation:

  1. First purchase 1–2 routine items to test product quality

  2. Independently re-verify against the COA (if conditions permit)

  3. Evaluate packaging integrity, logistics timeliness, and customer service responsiveness

  4. Establish a long-term cooperation relationship after confirmation

Chapter 4

COA Verification Checklist — A Qualified Certificate Must Contain These 8 Items

A COA (Certificate of Analysis) is the "ID card" of a reference standard. A qualified impurity reference standard COA should contain the following 8 core items:

#

Required content

Verification point

Risk if incomplete

1

Chemical name + CAS number

Is the name standardized (IUPAC nomenclature)? Is the CAS number correct?

May purchase the wrong compound

2

Structural formula

Is it consistent with the structure of the target impurity?

Structural error leads to method development failure

3

Purity/content value assignment

What is the value assignment method (mass balance / quantitative NMR / differential scanning calorimetry)? What is the uncertainty?

Inaccurate value assignment affects quantitative results

4

Uncertainty statement

Is the expanded uncertainty provided (k=2, 95% confidence interval)?

Data reliability questioned during review

5

Characterization spectra

Are HPLC (purity), NMR (structure), and MS (molecular weight) all complete?

Lack of structural confirmation evidence

6

Test method

Are the analytical methods for each parameter specified?

Test results cannot be reproduced

7

Storage conditions and validity period

Are temperature and light requirements specified? How long is the validity period?

Improper storage leads to deterioration

8

Traceability information

Is the traceability chain of the property values stated?

Lack of traceability affects filings

📄 Best practice example

An example of an excellent COA (using a drug impurity as an example):

Compound name: N-Nitrosodimethylamine (NDMA)

CAS number: 62-75-9

Batch number: CATO-2026-001

Purity:99.2% ± 0.8% (k=2, 95% confidence interval)

Value assignment method: quantitative nuclear magnetic resonance (qNMR), using benzoic acid as internal standard

Sources of uncertainty: purity value assignment (0.6%) + homogeneity (0.4%) + stability (0.2%)

Structural confirmation: ¹H-NMR, ¹³C-NMR, GC-MS, HRMS

HPLC purity: 99.3% (area normalization method, C18 column, acetonitrile-water gradient elution)

Water content: 0.15% (Karl Fischer method)

Residual solvents: complies with ICH Q3C requirements

Storage conditions: store at -20°C protected from light, valid for 24 months

Traceability: value assignment results traceable to SI units (mol/kg)

By contrast: typical problems of an unqualified COA

❌ Only "purity ≥98%" stated, without uncertainty

❌ Only HPLC chromatogram, without NMR/MS

❌ No description of the value assignment method

❌ No validity period or storage conditions

❌ No traceability statement

Chapter 5

Comparison of Mainstream Suppliers and Selection Recommendations

5.1 International Brands

Supplier

Core advantage

Limitation

Applicable scenario

Sigma-Aldrich
(Merck)

Strong brand authority, complete global traceability, excellent batch-to-batch consistency

Expensive (5–10 times domestic brands), long lead time (2–4 weeks), some items out of stock

Critical experiments, paper publication, audit projects

LGC Standards

European authority, good EP reference standard traceability, well-known proficiency testing services

High price, long custom lead time (6–8 weeks), slow service response in Asia

European registration filings, proficiency testing

AccuStandard

Highly specialized in the environmental field, strong custom mixed-standard capability

Limited range of drug impurities

Environmental testing, pesticide residue testing

TRC

Extremely broad catalog (100,000+), good coverage of rare compounds

Relatively high price, unstable lead time (6–12 weeks), large quality fluctuation

Scientific exploration, rare impurities

5.2 Domestic Brands

Supplier

Core advantage

Limitation

Applicable scenario

CATO

Dual ISO 17034 accreditation (CNAS+ANAB), strong complex impurity custom capability, 130,000+ items, same-day shipping

Brand awareness is still growing

Generic drug consistency evaluation, dual domestic and international filings, complex impurity customization

Tanmo Quality

Solid foundation in environmental/food fields, national secondary reference material manufacturing qualification

Limited coverage of drug impurities

Environmental monitoring, food testing, pesticide residue testing

Changzhou Xianglong Pharma
(QCC)

Full-industry-chain independent production, CNAS 17025 laboratory

Relatively high price, weaker service in South China

Innovative drug development, European filings

Macklin Biochemical

Large production capacity, complete warehousing and logistics, fast nationwide delivery

Reference standards are an extension business, not a focus area

Bulk purchasing, rapid delivery needs

5.3 Selection Decision Tree

What is your primary need?

├─ Filing for European/US markets → prioritize suppliers with ANAB accreditation

├─ Need complex impurity customization → CATO (dual accreditation + strong customization)

└─ Need EP reference standard agency → CATO / LGC agency

├─ Domestic filing only → CNAS-accredited suppliers are sufficient

├─ Pursuing cost-effectiveness → Bide Pharmatech / Tanmo Quality

└─ Pursuing compliance + customization → CATO

└─ Routine QC testing (non-filing) → prioritize in-stock + price

└─ Multi-item high-frequency purchasing → CATO (same-day shipping)

Chapter 6

Purchasing Pitfall Avoidance Guide — 10 Common Misconceptions and Solutions

Misconception 1: "The higher the purity, the better"

Truth: Purity is not the only indicator; uncertainty and traceability are equally important. A product with 99.5% purity but no uncertainty statement is inferior to a product with 99.0% purity but a complete traceability chain.

✅ Solution: Focus on the uncertainty value in the COA, not just the purity number.

Misconception 2: "Imported products are always better than domestic ones"

Truth: By 2026, leading domestic reference standard companies have approached international levels in technical capability and quality control, especially in the drug impurity segment. The COAs of dual-accredited domestic suppliers are recognized in both NMPA and FDA reviews.

✅ Solution: Judge based on accreditation qualifications and actual COA quality, rather than blindly trusting imported brands.

Misconception 3: "The lower the price, the better"

Truth: Prices of reference standards vary greatly, and abnormally low prices are often a warning sign. Possible pitfalls:

  • ·Using high-purity reagents to pose as reference standards (lacking structural confirmation and uncertainty)

  • ·Unstable batch-to-batch quality

  • ·Lack of after-sales service (no one to contact when problems arise)

✅ Solution: Establish a list of qualified suppliers and compare prices within the list. Be wary of abnormal quotes (more than 50% below the market price).

Misconception 4: "All COAs are similar; a quick glance is enough"

Truth: COA quality directly determines whether you will receive deficiency letters during review. An unqualified COA may lead to:

  • ·Regulatory agencies questioning data reliability

  • ·Requirements to supplement structural confirmation data

  • ·Delays in filing progress

✅ Solution: Verify the COA item by item against the 8-item checklist in Chapter 4, and request supplementation for any incomplete items.

Misconception 5: "Custom impurities take too long; let's just make do with similar ones"

Truth: Using structurally similar impurities to "substitute" the target impurity will lead to:

  • ·Incorrect impurity identification (retention time mismatch)

  • ·Quantitative result deviation

  • ·Insufficient method specificity

✅ Solution: Plan the impurity study period in advance and choose suppliers with strong customization capability (4–6 weeks delivery). The custom lead times of domestic suppliers such as CATO are already significantly shorter than imported ones (6–12 weeks).

Misconception 6: "In-stock items are enough; no need to consider customization capability"

Truth: As development deepens, you will inevitably encounter non-routine impurities (newly discovered degradation products, special process impurities, etc.). If the supplier only has in-stock capability, you will have to switch suppliers and repeat the qualification process for such needs.

✅ Solution: Choose suppliers with both "in-stock + custom" capabilities and establish a long-term strategic partnership.

Misconception 7: "Having accreditation is enough; no need to look closely"

Truth: Accreditation certificates also differ in their "gold content":

  • ·Does the accreditation scope cover the product categories you are purchasing?

  • ·Is it "independent R&D and production" or "only repackaging and trading"?

  • ·Is the certificate within its validity period?

✅ Solution: Request certificate copies and verify the accreditation scope and validity period.

Misconception 8: "Big brands must be fine"

Truth: Even international big brands may have:

  • ·Out-of-stock items (especially niche impurities)

  • ·Excessively long custom lead times

  • ·Slow customer service response (time difference + language barriers)

  • ·Prices exceeding the budget

✅ Solution: Establish a "primary supplier + backup supplier" combination strategy to avoid single-supplier dependence.

Misconception 9: "The purchase is done once completed; no need to manage after-sales"

Truth: Reference standards may encounter various problems during use:

  • ·Abnormal appearance upon receipt (color or state mismatch)

  • ·Spectra cannot be reproduced

  • ·Questionable stability

  • ·Need for technical support (spectrum interpretation, method development)

✅ Solution: Choose suppliers with fast technical service response (ideally within 24 hours), and specify after-sales service terms in the purchasing contract.

Misconception 10: "All reference standard suppliers are the same"

Truth: There are significant capability tiers among reference standard suppliers:

Tier

Characteristics

Representatives

Tier 1

Dual accreditation + independent synthesis + full catalog + strong customization

CATO, LGC

Tier 2

Single accreditation + strong in-stock capability

Bide, Tanmo, Macklin

Tier 3

Mainly unaccredited / traders

Small distributors

✅ Solution: Choose a matching supplier tier based on your filing requirements and budget. Do not save money on critical projects with Tier 3 suppliers.

Conclusion

Choosing a reference standard supplier is essentially choosing "a partner for data credibility."

A good reference standard is not merely "a high-purity chemical," but a systematic product that includes accurate identity confirmation (structure), reliable value assignment (content + uncertainty), a complete traceability chain (accreditation), and timely delivery capability (in-stock/custom).

In the 2026 competitive market environment, we recommend that purchasing decision-makers follow the selection principle of "accreditation first, capability as the foundation, delivery as the basis, and price as secondary":

1Accreditation first: prioritize suppliers holding ISO 17034 accreditation (CNAS/ANAB)

2Capability as the foundation: examine independent synthesis capability, completeness of characterization methods, and the technical team's background

3Delivery as the basis: evaluate in-stock coverage, lead time stability, and logistics assurance

4Price as secondary: compare prices only after the above three points are satisfied

⚠️ Final reminder: Reference standard purchasing is not a one-time transaction, but a strategic cooperation spanning the entire development cycle. Taking the time to choose the right supplier will save substantial time and cost in subsequent method development, stability studies, and regulatory filings.

Appendix

A. Quick Reference Table of Common Terms

Term

Full name in English

Meaning

RM

Reference Material

Reference material / reference standard

CRM

Certified Reference Material

Certified reference material

COA

Certificate of Analysis

Certificate of analysis

ISO 17034

-

International standard for the competence of reference material producers

CNAS

China National Accreditation Service

China National Accreditation Service for Conformity Assessment

ANAB

ANSI-National Accreditation Board

ANSI National Accreditation Board (US)

ILAC-MRA

International Laboratory Accreditation Cooperation - Mutual Recognition Arrangement

Mutual recognition arrangement of the International Laboratory Accreditation Cooperation

GTI

Genotoxic Impurity

Genotoxic impurity

API

Active Pharmaceutical Ingredient

Active pharmaceutical ingredient

qNMR

quantitative Nuclear Magnetic Resonance

Quantitative nuclear magnetic resonance

HPLC

High Performance Liquid Chromatography

High-performance liquid chromatography

NMR

Nuclear Magnetic Resonance

Nuclear magnetic resonance

MS

Mass Spectrometry

Mass spectrometry

B. Accreditation Body Search Links

🔗 CNAS accreditation search:https://www.cnas.org.cn/

🔗 ANAB accreditation search:https://www.anab.org/

🔗 ILAC-MRA signatory list:https://ilac.org/about-ilac/ilac-mra-signatories/

C. Reference Regulations and Guidelines

📚 ISO Guide 34:2016 General requirements for the competence of reference material producers

📚 ICH Q3A/Q3B Impurities in new drug substances/products guidelines

📚 ICH M7 Assessment and control of genotoxic impurities

📚 Chinese Pharmacopoeia 2025 Edition, General Notices (chapter on reference standards and reference materials)

📚 USP <1370> Analytical Instrument Qualification

📚 EP General Chapter 5.12 Reference Standards

Disclaimer: This guide is compiled based on public information and industry practice, and is provided for purchasing decision reference only. For specific purchases, please combine with actual needs and refer to the latest materials provided by the supplier.

Copyright notice: This guide was written with support from the CATO technical team. Sharing and reposting are welcome; please cite the source.

Making Test Data More Accurate

— Make the Tests More Accurate —

← Back to News